Abstract:This comprehensive review delves into the rapidly evolving arena of cancer vaccines. Initially, we examine the intricate constitution of the tumor microenvironment (TME), a dynamic factor that significantly influences tumor heterogeneity. Current research trends focusing on harnessing the TME for effective tumor vaccine treatments are also discussed. We then provide a detailed overview of the current state of research concerning tumor immunity and the mechanisms of tumor vaccines, describing the complex immunological processes involved. Furthermore, we conduct an exhaustive analysis of the contemporary research landscape of tumor vaccines, with a particular focus on peptide vaccines, DNA/RNA-based vaccines, viral-vector-based vaccines, dendritic-cell-based vaccines, and whole-cell-based vaccines. We analyze and summarize these categories of tumor vaccines, highlighting their individual advantages, limitations, and the factors influencing their effectiveness. In our survey of each category, we summarize commonly used tumor vaccines, aiming to provide readers with a more comprehensive understanding of the current state of tumor vaccine research. We then delve into an innovative strategy combining cancer vaccines with other therapies. By studying the effects of combining tumor vaccines with immune checkpoint inhibitors, radiotherapy, chemotherapy, targeted therapy, and oncolytic virotherapy, we establish that this approach can enhance overall treatment efficacy and offset the limitations of single-treatment approaches, offering patients more effective treatment options. Following this, we undertake a meticulous analysis of the entire process of personalized cancer vaccines, elucidating the intricate process from design, through research and production, to clinical application, thus helping readers gain a thorough understanding of its complexities. In conclusion, our exploration of tumor vaccines in this review aims to highlight their promising potential in cancer treatment. As research in this field continues to evolve, it undeniably holds immense promise for improving cancer patient outcomes.

Cancer Vaccines: Promising Therapeutics or an Unattainable Dream

Therapeutic cancer vaccines: advancements, challenges, and prospects

Advances in Therapeutic Cancer Vaccines, Their Obstacles, and Prospects Toward Tumor Immunotherapy

Recent Findings on Therapeutic Cancer Vaccines: An Updated Review

Advances in Cancer Vaccine Research

Cancer vaccines: the next immunotherapy frontier

Cancer vaccines: past, present and future; a review article

Turning the corner on therapeutic cancer vaccines

Recent Advances in Cancer Vaccines: Challenges, Achievements, and Futuristic Prospects

New Strategies for Therapeutic Cancer Vaccines.

Therapeutic Vaccines for Cancer Immunotherapy

Cancer Vaccines As Promising Immuno-Therapeutics: Platforms and Current Progress

Cancer Vaccines: Recent Insights and Future Directions

Recent progress in cancer vaccines and nanovaccines

Cancer Immunotherapy: an Evolving Paradigm

New Strategies to Improve Therapeutic Vaccines

Next-generation cancer vaccines and emerging immunotherapy combinations

Breast Cancer Vaccines: Disappointing or Promising?

Tumor Vaccines: Unleashing the Power of the Immune System to Fight Cancer

Unlocking cancer vaccine potential: What are the key factors?

Materials-Based Approaches for Cancer Vaccination